Vivos Therapeutics Inc
NASDAQ:VVOS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
US |
|
Hipay Group SA
PAR:ALHYP
|
FR |
|
A
|
Apar Industries Ltd
NSE:APARINDS
|
IN |
Wall Street
Price Targets
VVOS Price Targets Summary
Vivos Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VVOS
is 5.1 USD
with a low forecast of 2.53 USD and a high forecast of 7.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VVOS's stock price target?
Price Target
5.1
USD
According to Wall Street analysts, the average 1-year price target for
VVOS
is 5.1 USD
with a low forecast of 2.53 USD and a high forecast of 7.35 USD.
What is Vivos Therapeutics Inc's Revenue forecast?
Projected CAGR
40%
For the last 5 years the
compound annual growth rate for
Vivos Therapeutics Inc's revenue is
6%.
The projected
CAGR
for the next 2 years is
40%.
